c-Met inhibitor 2 inhibits the enzymatic activity of the c-Met tyrosine kinase, the receptor of hepatocyte growth factor/scatter factor (HGF/SF), interfering with pathways leading to cell growth and metastasis. It targets VEGFR1.
Molecular Weight
699.98
Molecular Formula
C28H29ClF2N5O10P
Targets
VEGFR1
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
c-Met inhibitor 2 helps in researching c-MET for its involvement in oncogenic processes and targeted cancer treatments.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
